{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T17:17:23Z","timestamp":1772990243677,"version":"3.50.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T00:00:00Z","timestamp":1752796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T00:00:00Z","timestamp":1752796800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["62472069"],"award-info":[{"award-number":["62472069"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"1.3.5 project for disciplines of excellence-Clinical Research Incubation Project, West China Hospital, Sichuan University","award":["2021HXFH001"],"award-info":[{"award-number":["2021HXFH001"]}]},{"name":"1.3.5 project for Artificial Intelligence West China Hospital, Sichuan University","award":["ZYAI24030"],"award-info":[{"award-number":["ZYAI24030"]}]},{"name":"China Telecom Sichuan Company Biliary Tract Tumor Big Data Platform and Application Phase I R&D Project","award":["312230752"],"award-info":[{"award-number":["312230752"]}]},{"name":"National Natural Science Foundation of China for Young Scientists Fund","award":["82203650"],"award-info":[{"award-number":["82203650"]}]},{"DOI":"10.13039\/501100018542","name":"Sichuan Natural Science Foundation","doi-asserted-by":"crossref","award":["2024NSFSC0742"],"award-info":[{"award-number":["2024NSFSC0742"]}],"id":[{"id":"10.13039\/501100018542","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Sichuan Science and Technology Program","award":["2024YFFK0384"],"award-info":[{"award-number":["2024YFFK0384"]}]},{"name":"Science and Technology project of the Health planning committee of Sichuan","award":["24QNMP031"],"award-info":[{"award-number":["24QNMP031"]}]},{"name":"Sichuan University-Sui Ning School-local Cooperation project","award":["2022CDSN-18"],"award-info":[{"award-number":["2022CDSN-18"]}]},{"name":"the Postdoctor Research Fund of West China Hospital, Sichuan University","award":["2024HXBH134"],"award-info":[{"award-number":["2024HXBH134"]}]},{"name":"(Qilu) Clinical Research of Sichuan Anticancer Association","award":["XH2023-032"],"award-info":[{"award-number":["XH2023-032"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-10876-4","type":"journal-article","created":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T01:08:43Z","timestamp":1752800923000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Integrating bulk and single cell sequencing data to identify prognostic biomarkers and drug candidates in HBV associated hepatocellular carcinoma"],"prefix":"10.1038","volume":"15","author":[{"given":"Yanjie","family":"Zhong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antony","family":"Stalin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yushi","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiqiang","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siqi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruiqi","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aoqiang","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fuyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haijie","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,18]]},"reference":[{"key":"10876_CR1","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.jhep.2023.01.011","volume":"78","author":"Y Liu","year":"2023","unstructured":"Liu, Y. et al. Identification of a tumour immune barrier in the HCC microenvironment that determines the efficacy of immunotherapy. J. Hepatol. 78, 770\u2013782. https:\/\/doi.org\/10.1016\/j.jhep.2023.01.011 (2023).","journal-title":"J. Hepatol."},{"key":"10876_CR2","doi-asserted-by":"publisher","unstructured":"Yang, Y. et al. O-GlcNAcylation of YTHDF2 promotes HBV-related hepatocellular carcinoma progression in an N(6)-methyladenosine-dependent manner. Signal. Transduct. Target. Therapy. 8 https:\/\/doi.org\/10.1038\/s41392-023-01316-8 (2023).","DOI":"10.1038\/s41392-023-01316-8"},{"key":"10876_CR3","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1016\/s0140-6736(18)30207-1","volume":"391","author":"M Kudo","year":"2018","unstructured":"Kudo, M. et al. Lenvatinib versus Sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial. Lancet (London England). 391, 1163\u20131173. https:\/\/doi.org\/10.1016\/s0140-6736(18)30207-1 (2018).","journal-title":"Lancet (London England)"},{"key":"10876_CR4","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1056\/NEJMoa1915745","volume":"382","author":"RS Finn","year":"2020","unstructured":"Finn, R. S. et al. Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma. N. Engl. J. Med. 382, 1894\u20131905. https:\/\/doi.org\/10.1056\/NEJMoa1915745 (2020).","journal-title":"N. Engl. J. Med."},{"key":"10876_CR5","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1136\/gutjnl-2018-316510","volume":"68","author":"CJ Lim","year":"2019","unstructured":"Lim, C. J. et al. Multidimensional analyses reveal distinct immune microenvironment in hepatitis B virus-related hepatocellular carcinoma. Gut 68, 916\u2013927. https:\/\/doi.org\/10.1136\/gutjnl-2018-316510 (2019).","journal-title":"Gut"},{"key":"10876_CR6","doi-asserted-by":"publisher","first-page":"3684","DOI":"10.1038\/s41467-021-24010-1","volume":"12","author":"DW Ho","year":"2021","unstructured":"Ho, D. W. et al. Single-cell RNA sequencing shows the immunosuppressive landscape and tumor heterogeneity of HBV-associated hepatocellular carcinoma. Nat. Commun. 12, 3684. https:\/\/doi.org\/10.1038\/s41467-021-24010-1 (2021).","journal-title":"Nat. Commun."},{"key":"10876_CR7","doi-asserted-by":"publisher","unstructured":"Yin, D. et al. Novel insights into HBV-hepatocellular carcinoma at single-cell sequencing. 2, e60,  https:\/\/doi.org\/10.1002\/mog2.60 (2023).","DOI":"10.1002\/mog2.60"},{"key":"10876_CR8","doi-asserted-by":"publisher","unstructured":"Toledo, B. et al. Deciphering the performance of macrophages in tumour microenvironment: a call for precision immunotherapy. J. Hematol. Oncol. 17 https:\/\/doi.org\/10.1186\/s13045-024-01559-0 (2024).","DOI":"10.1186\/s13045-024-01559-0"},{"key":"10876_CR9","doi-asserted-by":"publisher","unstructured":"Kretschmer, C. et al. Identification of early molecular markers for breast cancer. Mol. Cancer. 10 https:\/\/doi.org\/10.1186\/1476-4598-10-15 (2011).","DOI":"10.1186\/1476-4598-10-15"},{"key":"10876_CR10","doi-asserted-by":"publisher","unstructured":"Lamort, A. S., Giopanou, I., Psallidas, I. & Stathopoulos, G. T. Osteopontin as a link between inflammation and cancer: the thorax in the spotlight. Cells 8 https:\/\/doi.org\/10.3390\/cells8080815 (2019).","DOI":"10.3390\/cells8080815"},{"key":"10876_CR11","doi-asserted-by":"publisher","first-page":"1175490","DOI":"10.3389\/fimmu.2023.1175490","volume":"14","author":"S Yu","year":"2023","unstructured":"Yu, S., Chen, M., Xu, L., Mao, E. & Sun, S. A senescence-based prognostic gene signature for colorectal cancer and identification of the role of SPP1-positive macrophages in tumor senescence. Front. Immunol. 14, 1175490. https:\/\/doi.org\/10.3389\/fimmu.2023.1175490 (2023).","journal-title":"Front. Immunol."},{"key":"10876_CR12","doi-asserted-by":"publisher","unstructured":"Matsubara, E. et al. The significance of SPP1 in lung cancers and its impact as a marker for protumor Tumor-Associated macrophages. Cancers 15 https:\/\/doi.org\/10.3390\/cancers15082250 (2023).","DOI":"10.3390\/cancers15082250"},{"key":"10876_CR13","doi-asserted-by":"publisher","first-page":"e0116644","DOI":"10.1371\/journal.pone.0116644","volume":"10","author":"F Szulzewsky","year":"2015","unstructured":"Szulzewsky, F. et al. Glioma-associated microglia\/macrophages display an expression profile different from M1 and M2 polarization and highly express Gpnmb and Spp1. PLoS One. 10, e0116644. https:\/\/doi.org\/10.1371\/journal.pone.0116644 (2015).","journal-title":"PLoS One"},{"key":"10876_CR14","doi-asserted-by":"publisher","first-page":"3069","DOI":"10.1093\/bioinformatics\/btv313","volume":"31","author":"M Yoo","year":"2015","unstructured":"Yoo, M. et al. DSigDB: drug signatures database for gene set analysis. Bioinformatics 31, 3069\u20133071. https:\/\/doi.org\/10.1093\/bioinformatics\/btv313 (2015).","journal-title":"Bioinformatics"},{"key":"10876_CR15","doi-asserted-by":"publisher","first-page":"4331","DOI":"10.3390\/ijms20184331","volume":"20","author":"L Pinzi","year":"2015","unstructured":"Pinzi, L. & Rastelli, G. Molecular docking: shifting paradigms in drug discovery. Int. J. Mol. Sci. 20, 4331. https:\/\/doi.org\/10.3390\/ijms20184331 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"10876_CR16","doi-asserted-by":"publisher","unstructured":"Wang, S. M., Ooi, L. L. P. J. & Hui, K. M. Identification and validation of a novel gene signature associated Wit h the recurrence of human hepatocellular carcinoma. Clinical cancer Research: Official J. Am. Associa Tion Cancer Research 13, 6275\u20136283, https:\/\/doi.org\/10.1158\/1078-0432.CCR-06-2236 (2007).","DOI":"10.1158\/1078-0432.CCR-06-2236"},{"key":"10876_CR17","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1038\/ng.2764","volume":"45","author":"K Chang","year":"2013","unstructured":"Chang, K. et al. The Cancer genome atlas Pan-Cancer analysis project. Nat. Genet. 45, 1113\u20131120. https:\/\/doi.org\/10.1038\/ng.2764 (2013).","journal-title":"Nat. Genet."},{"key":"10876_CR18","doi-asserted-by":"publisher","first-page":"180015","DOI":"10.1038\/sdata.2018.15","volume":"5","author":"S Bhattacharya","year":"2018","unstructured":"Bhattacharya, S. et al. ImmPort, toward repurposing of open access immunological assay data for translational and clinical research. Sci. Data. 5, 180015. https:\/\/doi.org\/10.1038\/sdata.2018.15 (2018).","journal-title":"Sci. Data"},{"key":"10876_CR19","doi-asserted-by":"publisher","unstructured":"Roessler, S. et al. A unique metastasis gene signature enables prediction of tumor relapse in early-stage hepatocellular carcinoma patients. Cancer Research 70, 10202\u201310212, https:\/\/doi.org\/10.1158\/0008-5472.CAN-10-2607 (2010).","DOI":"10.1158\/0008-5472.CAN-10-2607"},{"key":"10876_CR20","doi-asserted-by":"publisher","unstructured":"Grinchuk, O. V. et al. Tumor-adjacent tissue co-expression profile analysis reveals pro-oncog enic ribosomal gene signature for prognosis of resectable hepatocellul ar carcinoma. Molecular Oncology 12, 89\u2013113, https:\/\/doi.org\/10.1002\/1878-0261.12153 (2018).","DOI":"10.1002\/1878-0261.12153"},{"key":"10876_CR21","doi-asserted-by":"publisher","unstructured":"Li, B., Cao, Y., Li, Y., Cheng, C. & Yu, D. Letter to the editor: the inflamed subclass predicts immunotherapy res ponse - external validations. Gut, gutjnl-2022-328130, https:\/\/doi.org\/10.1136\/gutjnl-2022-328130 (2023).","DOI":"10.1136\/gutjnl-2022-328130"},{"key":"10876_CR22","doi-asserted-by":"publisher","unstructured":"Melis, M. et al. Viral expression and molecular profiling in liver tissue versus microd issected hepatocytes in hepatitis B virus-associated hepatocellular Ca rcinoma. Journal Translational Medicine 12, 230, https:\/\/doi.org\/10.1186\/s12967-014-0230-1 (2014).","DOI":"10.1186\/s12967-014-0230-1"},{"key":"10876_CR23","doi-asserted-by":"publisher","unstructured":"Ueda, T. et al. Gene expression profiling of Hepatitis B- and Hepatitis C-related Hepa Tocellular carcinoma using graphical Gaussian modeling. Genomics 101, 238\u2013248, https:\/\/doi.org\/10.1016\/j.ygeno.2013.02.007 (2014).","DOI":"10.1016\/j.ygeno.2013.02.007"},{"key":"10876_CR24","doi-asserted-by":"publisher","unstructured":"Zhou, W. et al. Predictive model for inflammation grades of chronic hepatitis B: large -scale analysis of clinical parameters and gene expressions. Liver Int 37, 1632\u20131641, https:\/\/doi.org\/10.1111\/liv.13427 (2017).","DOI":"10.1111\/liv.13427"},{"key":"10876_CR25","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/s41467-022-28421-6","volume":"13","author":"Z Liu","year":"2022","unstructured":"Liu, Z. et al. Machine learning-based integration develops an immune-derived LncRNA signature for improving outcomes in colorectal cancer. Nat. Commun. 13, 816. https:\/\/doi.org\/10.1038\/s41467-022-28421-6 (2022).","journal-title":"Nat. Commun."},{"key":"10876_CR26","doi-asserted-by":"publisher","first-page":"216594","DOI":"10.1016\/j.canlet.2023.216594","volume":"582","author":"W Hong","year":"2024","unstructured":"Hong, W. et al. Deciphering the immune modulation through deep transcriptomic profiling and therapeutic implications of DNA damage repair pattern in hepatocellular carcinoma. Cancer Lett. 582, 216594. https:\/\/doi.org\/10.1016\/j.canlet.2023.216594 (2024).","journal-title":"Cancer Lett."},{"key":"10876_CR27","doi-asserted-by":"publisher","first-page":"121792","DOI":"10.1016\/j.lfs.2023.121792","volume":"326","author":"Y Zhu","year":"2023","unstructured":"Zhu, Y. et al. Comprehensive bioinformatics and experimental analysis of SH3PXD2B reveals its carcinogenic effect in gastric carcinoma. Life Sci. 326, 121792. https:\/\/doi.org\/10.1016\/j.lfs.2023.121792 (2023).","journal-title":"Life Sci."},{"key":"10876_CR28","doi-asserted-by":"publisher","unstructured":"Cao, Y., Yang, Y., Hu, Q. & Wei, G. Identification of potential drug targets for rheumatoid arthritis from genetic insights: a Mendelian randomization study. J. Translational Med. 21 https:\/\/doi.org\/10.1186\/s12967-023-04474-z (2023).","DOI":"10.1186\/s12967-023-04474-z"},{"key":"10876_CR29","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkae909","volume":"53","author":"M Kanehisa","year":"2025","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Matsuura, Y. & Ishiguro-Watanabe, M. KEGG: biological systems database as a model of the real world. Nucleic Acids Res. 53, D672\u2013d677. https:\/\/doi.org\/10.1093\/nar\/gkae909 (2025).","journal-title":"Nucleic Acids Res."},{"key":"10876_CR30","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/pro.3715","volume":"28","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa, M. Toward Understanding the origin and evolution of cellular organisms. Protein Science: Publication Protein Soc. 28, 1947\u20131951. https:\/\/doi.org\/10.1002\/pro.3715 (2019).","journal-title":"Protein Science: Publication Protein Soc."},{"key":"10876_CR31","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27\u201330. https:\/\/doi.org\/10.1093\/nar\/28.1.27 (2000).","journal-title":"Nucleic Acids Res."},{"key":"10876_CR32","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.it.2022.04.008","volume":"43","author":"RY Ma","year":"2022","unstructured":"Ma, R. Y., Black, A. & Qian, B. Z. Macrophage diversity in cancer revisited in the era of single-cell omics. Trends Immunol. 43, 546\u2013563. https:\/\/doi.org\/10.1016\/j.it.2022.04.008 (2022).","journal-title":"Trends Immunol."},{"key":"10876_CR33","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.jhep.2021.08.029","volume":"76","author":"Y Gao","year":"2022","unstructured":"Gao, Y. et al. Intratumoral stem-like CCR4\u2009+\u2009regulatory T cells orchestrate the immunosuppressive microenvironment in HCC associated with hepatitis B. J. Hepatol. 76, 148\u2013159. https:\/\/doi.org\/10.1016\/j.jhep.2021.08.029 (2022).","journal-title":"J. Hepatol."},{"key":"10876_CR34","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1136\/gutjnl-2020-323153","volume":"71","author":"C P\u00e9neau","year":"2022","unstructured":"P\u00e9neau, C. et al. Hepatitis B virus integrations promote local and distant oncogenic driver alterations in hepatocellular carcinoma. Gut 71, 616\u2013626. https:\/\/doi.org\/10.1136\/gutjnl-2020-323153 (2022).","journal-title":"Gut"},{"key":"10876_CR35","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1093\/nsr\/nwu038","volume":"1","author":"P Yang","year":"2014","unstructured":"Yang, P., Markowitz, G. J. & Wang, X. F. The hepatitis B virus-associated tumor microenvironment in hepatocellular carcinoma. Natl. Sci. Rev. 1, 396\u2013412. https:\/\/doi.org\/10.1093\/nsr\/nwu038 (2014).","journal-title":"Natl. Sci. Rev."},{"key":"10876_CR36","doi-asserted-by":"publisher","first-page":"2701","DOI":"10.1016\/j.immuni.2021.11.015","volume":"54","author":"DY Oh","year":"2021","unstructured":"Oh, D. Y. & Fong, L. Cytotoxic CD4(+) T cells in cancer: expanding the immune effector toolbox. Immunity 54, 2701\u20132711. https:\/\/doi.org\/10.1016\/j.immuni.2021.11.015 (2021).","journal-title":"Immunity"},{"key":"10876_CR37","doi-asserted-by":"publisher","first-page":"1271236","DOI":"10.3389\/fimmu.2023.1271236","volume":"14","author":"A Malyshkina","year":"2023","unstructured":"Malyshkina, A., Br\u00fcggemann, A., Paschen, A. & Dittmer, U. Cytotoxic CD4(+) T cells in chronic viral infections and cancer. Front. Immunol. 14, 1271236. https:\/\/doi.org\/10.3389\/fimmu.2023.1271236 (2023).","journal-title":"Front. Immunol."},{"key":"10876_CR38","doi-asserted-by":"publisher","first-page":"11170","DOI":"10.18632\/aging.102521","volume":"11","author":"K Wang","year":"2019","unstructured":"Wang, K. et al. Identification of differentially expressed genes in non-small cell lung cancer. Aging 11, 11170\u201311185. https:\/\/doi.org\/10.18632\/aging.102521 (2019).","journal-title":"Aging"},{"key":"10876_CR39","doi-asserted-by":"publisher","unstructured":"Lawal, B. et al. Multi-Omics data analysis of gene expressions and alterations, Cancer-Associated fibroblast and immune infiltrations, reveals the Onco-Immune prognostic relevance of STAT3\/CDK2\/4\/6 in human malignancies. Cancers 13 https:\/\/doi.org\/10.3390\/cancers13050954 (2021).","DOI":"10.3390\/cancers13050954"},{"key":"10876_CR40","doi-asserted-by":"publisher","unstructured":"Yi, X. et al. SPP1 facilitates cell migration and invasion by targeting COL11A1 in lung adenocarcinoma. Cancer Cell Int. 22 https:\/\/doi.org\/10.1186\/s12935-022-02749-x (2022).","DOI":"10.1186\/s12935-022-02749-x"},{"key":"10876_CR41","doi-asserted-by":"publisher","first-page":"e23783","DOI":"10.1096\/fj.202400622RR","volume":"38","author":"Z Zhang","year":"2024","unstructured":"Zhang, Z. et al. SPP1 could be an immunological and prognostic biomarker: from pan-cancer comprehensive analysis to osteosarcoma validation. FASEB Journal: Official Publication Federation Am. Soc. Experimental Biology. 38, e23783. https:\/\/doi.org\/10.1096\/fj.202400622RR (2024).","journal-title":"FASEB Journal: Official Publication Federation Am. Soc. Experimental Biology"},{"key":"10876_CR42","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.2147\/ott.S154215","volume":"11","author":"B Zeng","year":"2018","unstructured":"Zeng, B., Zhou, M., Wu, H. & Xiong, Z. SPP1 promotes ovarian cancer progression via integrin \u03b21\/FAK\/AKT signaling pathway. OncoTargets Therapy. 11, 1333\u20131343. https:\/\/doi.org\/10.2147\/ott.S154215 (2018).","journal-title":"OncoTargets Therapy"},{"key":"10876_CR43","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1053\/j.gastro.2013.04.056","volume":"145","author":"MH Kim","year":"2013","unstructured":"Kim, M. H., Kang, S. G., Park, J. H., Yanagisawa, M. & Kim, C. H. Short-Chain fatty acids activate GPR41 and GPR43 on intestinal epithelial cells to promote inflammatory responses in mice. Gastroenterology 145, 396\u2013406e310. https:\/\/doi.org\/10.1053\/j.gastro.2013.04.056 (2013).","journal-title":"Gastroenterology"},{"key":"10876_CR44","doi-asserted-by":"publisher","first-page":"88","DOI":"10.3892\/ijo.2013.1951","volume":"43","author":"M Hishida","year":"2013","unstructured":"Hishida, M. et al. Estrogen receptor 1 gene as a tumor suppressor gene in hepatocellular carcinoma detected by triple-combination array analysis. Int. J. Oncol. 43, 88\u201394. https:\/\/doi.org\/10.3892\/ijo.2013.1951 (2013).","journal-title":"Int. J. Oncol."},{"key":"10876_CR45","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.3892\/etm.2017.4255","volume":"13","author":"F Ma","year":"2017","unstructured":"Ma, F. et al. miR-148a suppresses Estrogen-induced viability and migration of breast cancer cells via Inhibition of Estrogen receptor \u03b1 expression. Experimental Therapeutic Med. 13, 2515\u20132522. https:\/\/doi.org\/10.3892\/etm.2017.4255 (2017).","journal-title":"Experimental Therapeutic Med."},{"key":"10876_CR46","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/s13046-020-01724-6","volume":"39","author":"F Mudassar","year":"2020","unstructured":"Mudassar, F., Shen, H., O\u2019Neill, G. & Hau, E. Targeting tumor hypoxia and mitochondrial metabolism with anti-parasitic drugs to improve radiation response in high-grade gliomas. J. Experimental Clin. cancer Research: CR. 39, 208. https:\/\/doi.org\/10.1186\/s13046-020-01724-6 (2020).","journal-title":"J. Experimental Clin. cancer Research: CR"},{"key":"10876_CR47","doi-asserted-by":"publisher","unstructured":"Tao, Q. et al. Mefloquine enhances the efficacy of anti-PD-1 immunotherapy via IFN-\u03b3-STAT1-IRF1-LPCAT3-induced ferroptosis in tumors. J. Immunother. Cancer. 12 https:\/\/doi.org\/10.1136\/jitc-2023-008554 (2024).","DOI":"10.1136\/jitc-2023-008554"},{"key":"10876_CR48","doi-asserted-by":"publisher","first-page":"709526","DOI":"10.3389\/fphar.2021.709526","volume":"12","author":"W Yang","year":"2021","unstructured":"Yang, W. et al. Myricetin induces autophagy and cell cycle arrest of HCC by inhibiting MARCH1-Regulated Stat3 and p38 MAPK signaling pathways. Front. Pharmacol. 12, 709526. https:\/\/doi.org\/10.3389\/fphar.2021.709526 (2021).","journal-title":"Front. Pharmacol."},{"key":"10876_CR49","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1002\/ptr.7427","volume":"36","author":"M Wang","year":"2022","unstructured":"Wang, M. et al. Myricetin reverses epithelial-endothelial transition and inhibits vasculogenic mimicry and angiogenesis of hepatocellular carcinoma by directly targeting PAR1. Phytother. Res. 36, 1807\u20131821. https:\/\/doi.org\/10.1002\/ptr.7427 (2022).","journal-title":"Phytother. Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-10876-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-10876-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-10876-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T01:08:45Z","timestamp":1752800925000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-10876-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,18]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["10876"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-10876-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,18]]},"assertion":[{"value":"2 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests\u00a0"}},{"value":"The data utilized in this study is exclusively obtained from publicly available sources, eliminating the need for ethical scrutiny.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"26038"}}